APO Research
Talk to an analyst

APO RESEARCH · REPORT

Receptor Tyrosine Protein Kinase ERBB 4

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Receptor Tyrosine Protein Kinase ERBB 4 Market Analysis and Forecast 2026-2032

19 December 2025196 pages

Choose your research edition.

Industry ResearchReceptor Tyrosine Protein Kinase ERBB 4 Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Receptor Tyrosine Protein Kinase ERBB 4 Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Receptor Tyrosine Protein Kinase ERBB 4 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Receptor Tyrosine Protein Kinase ERBB 4 Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Receptor Tyrosine Protein Kinase ERBB 4 Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Receptor Tyrosine Protein Kinase ERBB 4 market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Receptor Tyrosine Protein Kinase ERBB 4 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Receptor Tyrosine Protein Kinase ERBB 4 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Receptor Tyrosine Protein Kinase ERBB 4 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Receptor Tyrosine Protein Kinase ERBB 4 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Receptor Tyrosine Protein Kinase ERBB 4 include Shanghai Fosun Pharmaceutical (Group) Co Ltd, XuanZhu Pharma Co Ltd, Jiangsu Kanion Pharmaceutical Co Ltd, Pfizer Inc, Hanmi Pharmaceuticals Co Ltd, Zensun (Shanghai) Sci & Tech Co Ltd, Puma Biotechnology Inc, Minerva Neurosciences Inc and GamaMabs Pharma SA, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Receptor Tyrosine Protein Kinase ERBB 4, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Receptor Tyrosine Protein Kinase ERBB 4, also provides the sales of main regions and countries. Of the upcoming market potential for Receptor Tyrosine Protein Kinase ERBB 4, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Receptor Tyrosine Protein Kinase ERBB 4 sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Receptor Tyrosine Protein Kinase ERBB 4 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Receptor Tyrosine Protein Kinase ERBB 4 sales, projected growth trends, production technology, application and end-user industry.

Receptor Tyrosine Protein Kinase ERBB 4 Segment by Company

Shanghai Fosun Pharmaceutical (Group) Co Ltd

XuanZhu Pharma Co Ltd

Jiangsu Kanion Pharmaceutical Co Ltd

Pfizer Inc

Hanmi Pharmaceuticals Co Ltd

Zensun (Shanghai) Sci & Tech Co Ltd

Puma Biotechnology Inc

Minerva Neurosciences Inc

GamaMabs Pharma SA

Boehringer Ingelheim GmbH

Aslan Pharmaceuticals Pte Ltd

Receptor Tyrosine Protein Kinase ERBB 4 Segment by Type

MIN-301

NRG-4

NT-113

PB-357

Others

Receptor Tyrosine Protein Kinase ERBB 4 Segment by Application

Systolic Heart Failure

Neuroblastoma

Oligodendroglioma

Skin Cancer

Others

Receptor Tyrosine Protein Kinase ERBB 4 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Receptor Tyrosine Protein Kinase ERBB 4 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Receptor Tyrosine Protein Kinase ERBB 4 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Receptor Tyrosine Protein Kinase ERBB 4.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Receptor Tyrosine Protein Kinase ERBB 4 in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Receptor Tyrosine Protein Kinase ERBB 4 manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Receptor Tyrosine Protein Kinase ERBB 4 sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Receptor Tyrosine Protein Kinase ERBB 4 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. MIN-301 Major Manufacturers Table 3. NRG-4 Major Manufacturers Table 4. NT-113 Major Manufacturers Table 5. PB-357 Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Receptor Tyrosine Protein Kinase ERBB 4 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Systolic Heart Failure Major Manufacturers Table 9. Neuroblastoma Major Manufacturers Table 10. Oligodendroglioma Major Manufacturers Table 11. Skin Cancer Major Manufacturers Table 12. Others Major Manufacturers Table 13. Receptor Tyrosine Protein Kinase ERBB 4 Industry Trends Table 14. Receptor Tyrosine Protein Kinase ERBB 4 Industry Drivers Table 15. Receptor Tyrosine Protein Kinase ERBB 4 Industry Opportunities and Challenges Table 16. Receptor Tyrosine Protein Kinase ERBB 4 Industry Restraints Table 17. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Region (2021-2026) Table 21. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Region (2027-2032) Table 22. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 23. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Region (2021-2026) & (K Units) Table 24. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Region (2027-2032) & (K Units) Table 25. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Region (2021-2026) Table 26. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Region (2027-2032) Table 27. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Manufacturers (2021-2026) Table 31. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 32. Global Receptor Tyrosine Protein Kinase ERBB 4 Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Receptor Tyrosine Protein Kinase ERBB 4 Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Receptor Tyrosine Protein Kinase ERBB 4 Manufacturers, Product Type & Application Table 35. Global Receptor Tyrosine Protein Kinase ERBB 4 Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Receptor Tyrosine Protein Kinase ERBB 4 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Type (2021-2026) Table 42. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Type (2027-2032) Table 43. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 44. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type (2021-2026) & (K Units) Table 45. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type (2027-2032) & (K Units) Table 46. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Type (2021-2026) Table 47. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Type (2027-2032) Table 48. Global Receptor Tyrosine Protein Kinase ERBB 4 Price by Type (2021-2026) & (US$/Unit) Table 49. Global Receptor Tyrosine Protein Kinase ERBB 4 Price by Type (2027-2032) & (US$/Unit) Table 50. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Application (2021-2026) Table 54. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Application (2027-2032) Table 55. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 56. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application (2021-2026) & (K Units) Table 57. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application (2027-2032) & (K Units) Table 58. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Application (2021-2026) Table 59. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Application (2027-2032) Table 60. Global Receptor Tyrosine Protein Kinase ERBB 4 Price by Application (2021-2026) & (US$/Unit) Table 61. Global Receptor Tyrosine Protein Kinase ERBB 4 Price by Application (2027-2032) & (US$/Unit) Table 62. Shanghai Fosun Pharmaceutical (Group) Co Ltd Company Information Table 63. Shanghai Fosun Pharmaceutical (Group) Co Ltd Business Overview Table 64. Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio Table 66. Shanghai Fosun Pharmaceutical (Group) Co Ltd Recent Development Table 67. XuanZhu Pharma Co Ltd Company Information Table 68. XuanZhu Pharma Co Ltd Business Overview Table 69. XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio Table 71. XuanZhu Pharma Co Ltd Recent Development Table 72. Jiangsu Kanion Pharmaceutical Co Ltd Company Information Table 73. Jiangsu Kanion Pharmaceutical Co Ltd Business Overview Table 74. Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio Table 76. Jiangsu Kanion Pharmaceutical Co Ltd Recent Development Table 77. Pfizer Inc Company Information Table 78. Pfizer Inc Business Overview Table 79. Pfizer Inc Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Pfizer Inc Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio Table 81. Pfizer Inc Recent Development Table 82. Hanmi Pharmaceuticals Co Ltd Company Information Table 83. Hanmi Pharmaceuticals Co Ltd Business Overview Table 84. Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio Table 86. Hanmi Pharmaceuticals Co Ltd Recent Development Table 87. Zensun (Shanghai) Sci & Tech Co Ltd Company Information Table 88. Zensun (Shanghai) Sci & Tech Co Ltd Business Overview Table 89. Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio Table 91. Zensun (Shanghai) Sci & Tech Co Ltd Recent Development Table 92. Puma Biotechnology Inc Company Information Table 93. Puma Biotechnology Inc Business Overview Table 94. Puma Biotechnology Inc Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Puma Biotechnology Inc Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio Table 96. Puma Biotechnology Inc Recent Development Table 97. Minerva Neurosciences Inc Company Information Table 98. Minerva Neurosciences Inc Business Overview Table 99. Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio Table 101. Minerva Neurosciences Inc Recent Development Table 102. GamaMabs Pharma SA Company Information Table 103. GamaMabs Pharma SA Business Overview Table 104. GamaMabs Pharma SA Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. GamaMabs Pharma SA Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio Table 106. GamaMabs Pharma SA Recent Development Table 107. Boehringer Ingelheim GmbH Company Information Table 108. Boehringer Ingelheim GmbH Business Overview Table 109. Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio Table 111. Boehringer Ingelheim GmbH Recent Development Table 112. Aslan Pharmaceuticals Pte Ltd Company Information Table 113. Aslan Pharmaceuticals Pte Ltd Business Overview Table 114. Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio Table 116. Aslan Pharmaceuticals Pte Ltd Recent Development Table 117. North America Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Type (2021-2026) & (US$ Million) Table 118. North America Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Type (2027-2032) & (US$ Million) Table 119. North America Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type (2021-2026) & (K Units) Table 120. North America Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type (2027-2032) & (K Units) Table 121. North America Receptor Tyrosine Protein Kinase ERBB 4 Sales Price by Type (2021-2026) & (US$/Unit) Table 122. North America Receptor Tyrosine Protein Kinase ERBB 4 Sales Price by Type (2027-2032) & (US$/Unit) Table 123. North America Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Application (2021-2026) & (US$ Million) Table 124. North America Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Application (2027-2032) & (US$ Million) Table 125. North America Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application (2021-2026) & (K Units) Table 126. North America Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application (2027-2032) & (K Units) Table 127. North America Receptor Tyrosine Protein Kinase ERBB 4 Sales Price by Application (2021-2026) & (US$/Unit) Table 128. North America Receptor Tyrosine Protein Kinase ERBB 4 Sales Price by Application (2027-2032) & (US$/Unit) Table 129. North America Receptor Tyrosine Protein Kinase ERBB 4 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. North America Receptor Tyrosine Protein Kinase ERBB 4 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 131. North America Receptor Tyrosine Protein Kinase ERBB 4 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 132. North America Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 133. North America Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2021-2026) & (K Units) Table 134. North America Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2027-2032) & (K Units) Table 135. North America Receptor Tyrosine Protein Kinase ERBB 4 Sales Price by Country (2021-2026) & (US$/Unit) Table 136. North America Receptor Tyrosine Protein Kinase ERBB 4 Sales Price by Country (2027-2032) & (US$/Unit) Table 137. United States Receptor Tyrosine Protein Kinase ERBB 4 Revenue (2021-2032) & (US$ Million) Table 138. Canada Receptor Tyrosine Protein Kinase ERBB 4 Revenue (2021-2032) & (US$ Million) Table 139. Europe Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Type (2021-2026) & (US$ Million) Table 140. Europe Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Type (2027-2032) & (US$ Million) Table 141. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type (2021-2026) & (K Units) Table 142. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type (2027-2032) & (K Units) Table 143. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales Price by Type (2021-2026) & (US$/Unit) Table 144. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales Price by Type (2027-2032) & (US$/Unit) Table 145. Europe Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Application (2021-2026) & (US$ Million) Table 146. Europe Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Application (2027-2032) & (US$ Million) Table 147. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application (2021-2026) & (K Units) Table 148. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application (2027-2032) & (K Units) Table 149. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales Price by Application (2021-2026) & (US$/Unit) Table 150. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales Price by Application (2027-2032) & (US$/Unit) Table 151. Europe Receptor Tyrosine Protein Kinase ERBB 4 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. Europe Receptor Tyrosine Protein Kinase ERBB 4 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 153. Europe Receptor Tyrosine Protein Kinase ERBB 4 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 154. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 155. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2021-2026) & (K Units) Table 156. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2027-2032) & (K Units) Table 157. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales Price by Country (2021-2026) & (US$/Unit) Table 158. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales Price by Country (2027-2032) & (US$/Unit) Table 159. Germany Receptor Tyrosine Protein Kinase ERBB 4 Revenue (2021-2032) & (US$ Million) Table 160. France Receptor Tyrosine Protein Kinase ERBB 4 Revenue (2021-2032) & (US$ Million) Table 161. U.K. Receptor Tyrosine Protein Kinase ERBB 4 Revenue (2021-2032) & (US$ Million) Table 162. Italy Receptor Tyrosine Protein Kinase ERBB 4 Revenue (2021-2032) & (US$ Million) Table 163. Netherlands Receptor Tyrosine Protein Kinase ERBB 4 Revenue (2021-2032) & (US$ Million) Table 164. China Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Type (2021-2026) & (US$ Million) Table 165. China Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Type (2027-2032) & (US$ Million) Table 166. China Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type (2021-2026) & (K Units) Table 167. China Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type (2027-2032) & (K Units) Table 168. China Receptor Tyrosine Protein Kinase ERBB 4 Sales Price by Type (2021-2026) & (US$/Unit) Table 169. China Receptor Tyrosine Protein Kinase ERBB 4 Sales Price by Type (2027-2032) & (US$/Unit) Table 170. China Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Application (2021-2026) & (US$ Million) Table 171. China Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Application (2027-2032) & (US$ Million) Table 172. China Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application (2021-2026) & (K Units) Table 173. China Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application (2027-2032) & (K Units) Table 174. China Receptor Tyrosine Protein Kinase ERBB 4 Sales Price by Application (2021-2026) & (US$/Unit) Table 175. China Receptor Tyrosine Protein Kinase ERBB 4 Sales Price by Application (2027-2032) & (US$/Unit) Table 176. Asia Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Type (2021-2026) & (US$ Million) Table 177. Asia Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Type (2027-2032) & (US$ Million) Table 178. Asia Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type (2021-2026) & (K Units) Table 179. Asia Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type (2027-2032) & (K Units) Table 180. Asia Receptor Tyrosine Protein Kinase ERBB 4 Sales Price by Type (2021-2026) & (US$/Unit) Table 181. Asia Receptor Tyrosine Protein Kinase ERBB 4 Sales Price by Type (2027-2032) & (US$/Unit) Table 182. Asia Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Application (2021-2026) & (US$ Million) Table 183. Asia Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Application (2027-2032) & (US$ Million) Table 184. Asia Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application (2021-2026) & (K Units) Table 185. Asia Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application (2027-2032) & (K Units) Table 186. Asia Receptor Tyrosine Protein Kinase ERBB 4 Sales Price by Application (2021-2026) & (US$/Unit) Table 187. Asia Receptor Tyrosine Protein Kinase ERBB 4 Sales Price by Application (2027-2032) & (US$/Unit) Table 188. Asia Receptor Tyrosine Protein Kinase ERBB 4 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 189. Asia Receptor Tyrosine Protein Kinase ERBB 4 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 190. Asia Receptor Tyrosine Protein Kinase ERBB 4 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 191. Asia Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 192. Asia Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2021-2026) & (K Units) Table 193. Asia Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2027-2032) & (K Units) Table 194. Asia Receptor Tyrosine Protein Kinase ERBB 4 Sales Price by Country (2021-2026) & (US$/Unit) Table 195. Asia Receptor Tyrosine Protein Kinase ERBB 4 Sales Price by Country (2027-2032) & (US$/Unit) Table 196. Japan Receptor Tyrosine Protein Kinase ERBB 4 Revenue (2021-2032) & (US$ Million) Table 197. South Korea Receptor Tyrosine Protein Kinase ERBB 4 Revenue (2021-2032) & (US$ Million) Table 198. India Receptor Tyrosine Protein Kinase ERBB 4 Revenue (2021-2032) & (US$ Million) Table 199. Australia Receptor Tyrosine Protein Kinase ERBB 4 Revenue (2021-2032) & (US$ Million) Table 200. China Taiwan Receptor Tyrosine Protein Kinase ERBB 4 Revenue (2021-2032) & (US$ Million) Table 201. Southeast Asia Receptor Tyrosine Protein Kinase ERBB 4 Revenue (2021-2032) & (US$ Million) Table 202. SAMEA Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Type (2021-2026) & (US$ Million) Table 203. SAMEA Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Type (2027-2032) & (US$ Million) Table 204. SAMEA Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type (2021-2026) & (K Units) Table 205. SAMEA Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type (2027-2032) & (K Units) Table 206. SAMEA Receptor Tyrosine Protein Kinase ERBB 4 Sales Price by Type (2021-2026) & (US$/Unit) Table 207. SAMEA Receptor Tyrosine Protein Kinase ERBB 4 Sales Price by Type (2027-2032) & (US$/Unit) Table 208. SAMEA Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Application (2021-2026) & (US$ Million) Table 209. SAMEA Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Application (2027-2032) & (US$ Million) Table 210. SAMEA Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application (2021-2026) & (K Units) Table 211. SAMEA Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application (2027-2032) & (K Units) Table 212. SAMEA Receptor Tyrosine Protein Kinase ERBB 4 Sales Price by Application (2021-2026) & (US$/Unit) Table 213. SAMEA Receptor Tyrosine Protein Kinase ERBB 4 Sales Price by Application (2027-2032) & (US$/Unit) Table 214. SAMEA Receptor Tyrosine Protein Kinase ERBB 4 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 215. SAMEA Receptor Tyrosine Protein Kinase ERBB 4 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 216. SAMEA Receptor Tyrosine Protein Kinase ERBB 4 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 217. SAMEA Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 218. SAMEA Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2021-2026) & (K Units) Table 219. SAMEA Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2027-2032) & (K Units) Table 220. SAMEA Receptor Tyrosine Protein Kinase ERBB 4 Sales Price by Country (2021-2026) & (US$/Unit) Table 221. SAMEA Receptor Tyrosine Protein Kinase ERBB 4 Sales Price by Country (2027-2032) & (US$/Unit) Table 222. Brazil Receptor Tyrosine Protein Kinase ERBB 4 Revenue (2021-2032) & (US$ Million) Table 223. Argentina Receptor Tyrosine Protein Kinase ERBB 4 Revenue (2021-2032) & (US$ Million) Table 224. Chile Receptor Tyrosine Protein Kinase ERBB 4 Revenue (2021-2032) & (US$ Million) Table 225. Colombia Receptor Tyrosine Protein Kinase ERBB 4 Revenue (2021-2032) & (US$ Million) Table 226. Peru Receptor Tyrosine Protein Kinase ERBB 4 Revenue (2021-2032) & (US$ Million) Table 227. Saudi Arabia Receptor Tyrosine Protein Kinase ERBB 4 Revenue (2021-2032) & (US$ Million) Table 228. Israel Receptor Tyrosine Protein Kinase ERBB 4 Revenue (2021-2032) & (US$ Million) Table 229. UAE Receptor Tyrosine Protein Kinase ERBB 4 Revenue (2021-2032) & (US$ Million) Table 230. Turkey Receptor Tyrosine Protein Kinase ERBB 4 Revenue (2021-2032) & (US$ Million) Table 231. Iran Receptor Tyrosine Protein Kinase ERBB 4 Revenue (2021-2032) & (US$ Million) Table 232. Egypt Receptor Tyrosine Protein Kinase ERBB 4 Revenue (2021-2032) & (US$ Million) Table 233. Key Raw Materials Table 234. Raw Materials Key Suppliers Table 235. Receptor Tyrosine Protein Kinase ERBB 4 Distributors List Table 236. Receptor Tyrosine Protein Kinase ERBB 4 Customers List Table 237. Research Programs/Design for This Report Table 238. Authors List of This Report Table 239. Secondary Sources Table 240. Primary Sources List of Figures Figure 1. Receptor Tyrosine Protein Kinase ERBB 4 Image Figure 2. Global Receptor Tyrosine Protein Kinase ERBB 4 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Receptor Tyrosine Protein Kinase ERBB 4 Market Size Share 2021 VS 2025 VS 2032 Figure 4. MIN-301 Image Figure 5. NRG-4 Image Figure 6. NT-113 Image Figure 7. PB-357 Image Figure 8. Others Image Figure 9. Global Receptor Tyrosine Protein Kinase ERBB 4 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Receptor Tyrosine Protein Kinase ERBB 4 Market Size Share 2021 VS 2025 VS 2032 Figure 11. Systolic Heart Failure Image Figure 12. Neuroblastoma Image Figure 13. Oligodendroglioma Image Figure 14. Skin Cancer Image Figure 15. Others Image Figure 16. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue (2021-2032) & (US$ Million) Figure 18. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Region (2021-2032) Figure 21. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales (2021-2032) & (K Units) Figure 22. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 23. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Receptor Tyrosine Protein Kinase ERBB 4 Sales YoY (2021-2032) & (K Units) Figure 25. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales YoY (2021-2032) & (K Units) Figure 26. China Receptor Tyrosine Protein Kinase ERBB 4 Sales YoY (2021-2032) & (K Units) Figure 27. Asia (Excluding China) Receptor Tyrosine Protein Kinase ERBB 4 Sales YoY (2021-2032) & (K Units) Figure 28. South America, Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Sales YoY (2021-2032) & (K Units) Figure 29. Global Receptor Tyrosine Protein Kinase ERBB 4 Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Receptor Tyrosine Protein Kinase ERBB 4 Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Type (2021-2032) Figure 35. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Type (2021-2032) Figure 38. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Application (2021-2032) Figure 41. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 42. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Application (2021-2032) Figure 44. North America Receptor Tyrosine Protein Kinase ERBB 4 Revenue Share by Type (2021-2032) Figure 45. North America Receptor Tyrosine Protein Kinase ERBB 4 Sales Share by Type (2021-2032) Figure 46. North America Receptor Tyrosine Protein Kinase ERBB 4 Revenue Share by Application (2021-2032) Figure 47. North America Receptor Tyrosine Protein Kinase ERBB 4 Sales Share by Application (2021-2032) Figure 48. North America Receptor Tyrosine Protein Kinase ERBB 4 Revenue Share by Country (2021-2032) Figure 49. North America Receptor Tyrosine Protein Kinase ERBB 4 Sales Share by Country (2021-2032) Figure 50. Europe Receptor Tyrosine Protein Kinase ERBB 4 Revenue Share by Type (2021-2032) Figure 51. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales Share by Type (2021-2032) Figure 52. Europe Receptor Tyrosine Protein Kinase ERBB 4 Revenue Share by Application (2021-2032) Figure 53. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales Share by Application (2021-2032) Figure 54. Europe Receptor Tyrosine Protein Kinase ERBB 4 Revenue Share by Country (2021-2032) Figure 55. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales Share by Country (2021-2032) Figure 56. China Receptor Tyrosine Protein Kinase ERBB 4 Revenue Share by Type (2021-2032) Figure 57. China Receptor Tyrosine Protein Kinase ERBB 4 Sales Share by Type (2021-2032) Figure 58. China Receptor Tyrosine Protein Kinase ERBB 4 Revenue Share by Application (2021-2032) Figure 59. China Receptor Tyrosine Protein Kinase ERBB 4 Sales Share by Application (2021-2032) Figure 60. Asia Receptor Tyrosine Protein Kinase ERBB 4 Revenue Share by Type (2021-2032) Figure 61. Asia Receptor Tyrosine Protein Kinase ERBB 4 Sales Share by Type (2021-2032) Figure 62. Asia Receptor Tyrosine Protein Kinase ERBB 4 Revenue Share by Application (2021-2032) Figure 63. Asia Receptor Tyrosine Protein Kinase ERBB 4 Sales Share by Application (2021-2032) Figure 64. Asia Receptor Tyrosine Protein Kinase ERBB 4 Revenue Share by Country (2021-2032) Figure 65. Asia Receptor Tyrosine Protein Kinase ERBB 4 Sales Share by Country (2021-2032) Figure 66. SAMEA Receptor Tyrosine Protein Kinase ERBB 4 Revenue Share by Type (2021-2032) Figure 67. SAMEA Receptor Tyrosine Protein Kinase ERBB 4 Sales Share by Type (2021-2032) Figure 68. SAMEA Receptor Tyrosine Protein Kinase ERBB 4 Revenue Share by Application (2021-2032) Figure 69. SAMEA Receptor Tyrosine Protein Kinase ERBB 4 Sales Share by Application (2021-2032) Figure 70. SAMEA Receptor Tyrosine Protein Kinase ERBB 4 Revenue Share by Country (2021-2032) Figure 71. SAMEA Receptor Tyrosine Protein Kinase ERBB 4 Sales Share by Country (2021-2032) Figure 72. Receptor Tyrosine Protein Kinase ERBB 4 Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Receptor Tyrosine Protein Kinase ERBB 4 Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • MIN-301
  • NRG-4
  • NT-113
  • PB-357
  • Others
Applications
  • Systolic Heart Failure
  • Neuroblastoma
  • Oligodendroglioma
  • Skin Cancer
  • Others
Companies covered
  • Shanghai Fosun Pharmaceutical (Group) Co Ltd
  • XuanZhu Pharma Co Ltd
  • Jiangsu Kanion Pharmaceutical Co Ltd
  • Pfizer Inc
  • Hanmi Pharmaceuticals Co Ltd
  • Zensun (Shanghai) Sci & Tech Co Ltd
  • Puma Biotechnology Inc
  • Minerva Neurosciences Inc
  • GamaMabs Pharma SA
  • Boehringer Ingelheim GmbH
  • Aslan Pharmaceuticals Pte Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Receptor Tyrosine Protein Kinase ERBB 4 Market by Type
  3. 1.2.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 MIN-301
  5. 1.2.3 NRG-4
  6. 1.2.4 NT-113
  7. 1.2.5 PB-357
  8. 1.2.6 Others
  9. 1.3 Receptor Tyrosine Protein Kinase ERBB 4 Market by Application
  10. 1.3.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Systolic Heart Failure
  12. 1.3.3 Neuroblastoma
  13. 1.3.4 Oligodendroglioma
  14. 1.3.5 Skin Cancer
  15. 1.3.6 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Receptor Tyrosine Protein Kinase ERBB 4 Market Dynamics
  1. 2.1 Receptor Tyrosine Protein Kinase ERBB 4 Industry Trends
  2. 2.2 Receptor Tyrosine Protein Kinase ERBB 4 Industry Drivers
  3. 2.3 Receptor Tyrosine Protein Kinase ERBB 4 Industry Opportunities and Challenges
  4. 2.4 Receptor Tyrosine Protein Kinase ERBB 4 Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Region
  3. 3.2.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Region (2021-2026)
  5. 3.2.3 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Region (2027-2032)
  6. 3.2.4 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Region
  9. 3.4.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Region (2021-2026)
  11. 3.4.3 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Region (2027-2032)
  12. 3.4.4 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Manufacturers
  2. 4.1.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Receptor Tyrosine Protein Kinase ERBB 4 Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Manufacturers
  6. 4.2.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Receptor Tyrosine Protein Kinase ERBB 4 Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Receptor Tyrosine Protein Kinase ERBB 4 Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Receptor Tyrosine Protein Kinase ERBB 4 Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Receptor Tyrosine Protein Kinase ERBB 4 Manufacturers, Product Type & Application
  13. 4.7 Global Receptor Tyrosine Protein Kinase ERBB 4 Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Market CR5 and HHI
  16. 4.8.2 2025 Receptor Tyrosine Protein Kinase ERBB 4 Tier 1, Tier 2, and Tier 3
5 Receptor Tyrosine Protein Kinase ERBB 4 Market by Type
  1. 5.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Type
  2. 5.1.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type
  6. 5.2.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Type (2021-2032)
  9. 5.3 Global Receptor Tyrosine Protein Kinase ERBB 4 Price by Type
6 Receptor Tyrosine Protein Kinase ERBB 4 Market by Application
  1. 6.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Application
  2. 6.1.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application
  6. 6.2.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Application (2021-2032)
  9. 6.3 Global Receptor Tyrosine Protein Kinase ERBB 4 Price by Application
7 Company Profiles
  1. 7.1 Shanghai Fosun Pharmaceutical (Group) Co Ltd
  2. 7.1.1 Shanghai Fosun Pharmaceutical (Group) Co Ltd Company Information
  3. 7.1.2 Shanghai Fosun Pharmaceutical (Group) Co Ltd Business Overview
  4. 7.1.3 Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio
  6. 7.1.5 Shanghai Fosun Pharmaceutical (Group) Co Ltd Recent Developments
  7. 7.2 XuanZhu Pharma Co Ltd
  8. 7.2.1 XuanZhu Pharma Co Ltd Company Information
  9. 7.2.2 XuanZhu Pharma Co Ltd Business Overview
  10. 7.2.3 XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio
  12. 7.2.5 XuanZhu Pharma Co Ltd Recent Developments
  13. 7.3 Jiangsu Kanion Pharmaceutical Co Ltd
  14. 7.3.1 Jiangsu Kanion Pharmaceutical Co Ltd Company Information
  15. 7.3.2 Jiangsu Kanion Pharmaceutical Co Ltd Business Overview
  16. 7.3.3 Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio
  18. 7.3.5 Jiangsu Kanion Pharmaceutical Co Ltd Recent Developments
  19. 7.4 Pfizer Inc
  20. 7.4.1 Pfizer Inc Company Information
  21. 7.4.2 Pfizer Inc Business Overview
  22. 7.4.3 Pfizer Inc Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Pfizer Inc Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio
  24. 7.4.5 Pfizer Inc Recent Developments
  25. 7.5 Hanmi Pharmaceuticals Co Ltd
  26. 7.5.1 Hanmi Pharmaceuticals Co Ltd Company Information
  27. 7.5.2 Hanmi Pharmaceuticals Co Ltd Business Overview
  28. 7.5.3 Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio
  30. 7.5.5 Hanmi Pharmaceuticals Co Ltd Recent Developments
  31. 7.6 Zensun (Shanghai) Sci & Tech Co Ltd
  32. 7.6.1 Zensun (Shanghai) Sci & Tech Co Ltd Company Information
  33. 7.6.2 Zensun (Shanghai) Sci & Tech Co Ltd Business Overview
  34. 7.6.3 Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio
  36. 7.6.5 Zensun (Shanghai) Sci & Tech Co Ltd Recent Developments
  37. 7.7 Puma Biotechnology Inc
  38. 7.7.1 Puma Biotechnology Inc Company Information
  39. 7.7.2 Puma Biotechnology Inc Business Overview
  40. 7.7.3 Puma Biotechnology Inc Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Puma Biotechnology Inc Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio
  42. 7.7.5 Puma Biotechnology Inc Recent Developments
  43. 7.8 Minerva Neurosciences Inc
  44. 7.8.1 Minerva Neurosciences Inc Company Information
  45. 7.8.2 Minerva Neurosciences Inc Business Overview
  46. 7.8.3 Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio
  48. 7.8.5 Minerva Neurosciences Inc Recent Developments
  49. 7.9 GamaMabs Pharma SA
  50. 7.9.1 GamaMabs Pharma SA Company Information
  51. 7.9.2 GamaMabs Pharma SA Business Overview
  52. 7.9.3 GamaMabs Pharma SA Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 GamaMabs Pharma SA Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio
  54. 7.9.5 GamaMabs Pharma SA Recent Developments
  55. 7.10 Boehringer Ingelheim GmbH
  56. 7.10.1 Boehringer Ingelheim GmbH Company Information
  57. 7.10.2 Boehringer Ingelheim GmbH Business Overview
  58. 7.10.3 Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio
  60. 7.10.5 Boehringer Ingelheim GmbH Recent Developments
  61. 7.11 Aslan Pharmaceuticals Pte Ltd
  62. 7.11.1 Aslan Pharmaceuticals Pte Ltd Company Information
  63. 7.11.2 Aslan Pharmaceuticals Pte Ltd Business Overview
  64. 7.11.3 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio
  66. 7.11.5 Aslan Pharmaceuticals Pte Ltd Recent Developments
8 North America
  1. 8.1 North America Receptor Tyrosine Protein Kinase ERBB 4 Market Size by Type
  2. 8.1.1 North America Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Type (2021-2032)
  3. 8.1.2 North America Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type (2021-2032)
  4. 8.1.3 North America Receptor Tyrosine Protein Kinase ERBB 4 Price by Type (2021-2032)
  5. 8.2 North America Receptor Tyrosine Protein Kinase ERBB 4 Market Size by Application
  6. 8.2.1 North America Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Application (2021-2032)
  7. 8.2.2 North America Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application (2021-2032)
  8. 8.2.3 North America Receptor Tyrosine Protein Kinase ERBB 4 Price by Application (2021-2032)
  9. 8.3 North America Receptor Tyrosine Protein Kinase ERBB 4 Market Size by Country
  10. 8.3.1 North America Receptor Tyrosine Protein Kinase ERBB 4 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Receptor Tyrosine Protein Kinase ERBB 4 Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Receptor Tyrosine Protein Kinase ERBB 4 Market Size by Type
  2. 9.1.1 Europe Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Type (2021-2032)
  3. 9.1.2 Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type (2021-2032)
  4. 9.1.3 Europe Receptor Tyrosine Protein Kinase ERBB 4 Price by Type (2021-2032)
  5. 9.2 Europe Receptor Tyrosine Protein Kinase ERBB 4 Market Size by Application
  6. 9.2.1 Europe Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Application (2021-2032)
  7. 9.2.2 Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application (2021-2032)
  8. 9.2.3 Europe Receptor Tyrosine Protein Kinase ERBB 4 Price by Application (2021-2032)
  9. 9.3 Europe Receptor Tyrosine Protein Kinase ERBB 4 Market Size by Country
  10. 9.3.1 Europe Receptor Tyrosine Protein Kinase ERBB 4 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Receptor Tyrosine Protein Kinase ERBB 4 Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Receptor Tyrosine Protein Kinase ERBB 4 Market Size by Type
  2. 10.1.1 China Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Type (2021-2032)
  3. 10.1.2 China Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type (2021-2032)
  4. 10.1.3 China Receptor Tyrosine Protein Kinase ERBB 4 Price by Type (2021-2032)
  5. 10.2 China Receptor Tyrosine Protein Kinase ERBB 4 Market Size by Application
  6. 10.2.1 China Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Application (2021-2032)
  7. 10.2.2 China Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application (2021-2032)
  8. 10.2.3 China Receptor Tyrosine Protein Kinase ERBB 4 Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Receptor Tyrosine Protein Kinase ERBB 4 Market Size by Type
  2. 11.1.1 Asia Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Type (2021-2032)
  3. 11.1.2 Asia Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type (2021-2032)
  4. 11.1.3 Asia Receptor Tyrosine Protein Kinase ERBB 4 Price by Type (2021-2032)
  5. 11.2 Asia Receptor Tyrosine Protein Kinase ERBB 4 Market Size by Application
  6. 11.2.1 Asia Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Application (2021-2032)
  7. 11.2.2 Asia Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application (2021-2032)
  8. 11.2.3 Asia Receptor Tyrosine Protein Kinase ERBB 4 Price by Application (2021-2032)
  9. 11.3 Asia Receptor Tyrosine Protein Kinase ERBB 4 Market Size by Country
  10. 11.3.1 Asia Receptor Tyrosine Protein Kinase ERBB 4 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Receptor Tyrosine Protein Kinase ERBB 4 Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Receptor Tyrosine Protein Kinase ERBB 4 Market Size by Type
  2. 12.1.1 SAMEA Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Receptor Tyrosine Protein Kinase ERBB 4 Price by Type (2021-2032)
  5. 12.2 SAMEA Receptor Tyrosine Protein Kinase ERBB 4 Market Size by Application
  6. 12.2.1 SAMEA Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Receptor Tyrosine Protein Kinase ERBB 4 Price by Application (2021-2032)
  9. 12.3 SAMEA Receptor Tyrosine Protein Kinase ERBB 4 Market Size by Country
  10. 12.3.1 SAMEA Receptor Tyrosine Protein Kinase ERBB 4 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Receptor Tyrosine Protein Kinase ERBB 4 Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Receptor Tyrosine Protein Kinase ERBB 4 Value Chain Analysis
  2. 13.1.1 Receptor Tyrosine Protein Kinase ERBB 4 Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Receptor Tyrosine Protein Kinase ERBB 4 Production Mode & Process
  6. 13.2 Receptor Tyrosine Protein Kinase ERBB 4 Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Receptor Tyrosine Protein Kinase ERBB 4 Distributors
  9. 13.2.3 Receptor Tyrosine Protein Kinase ERBB 4 Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst